Nuclear Medicine: Page 98

SPECT/CT tracer shows promise for AAA risk evaluation

By AuntMinnie.com staff writers

Researchers at Yale University are developing a new SPECT/CT tracer that could potentially assess a patient's risk for abdominal aortic aneurysm (AAA) rupture, according to a study in the August issue of the Journal of Nuclear Medicine.

August 1, 2017

PET is center of attention at U.K. Alzheimer's conference

By Wayne Forrest

While PET can accurately detect or exclude Alzheimer's disease by imaging beta-amyloid plaques in the brain, the modality is underutilized in clinical care, according to research presented this week at the Alzheimer's Association International Conference in London.

July 18, 2017

Radiotherapy boost based on PET not always helpful

By Wayne Forrest

Selectively increasing radiotherapy dose in tumor areas with significant uptake of the PET radiotracer F-18 fluoromisonidazole (FMISO) does not necessarily improve outcomes for non-small cell lung cancer patients, according to a phase II study published in the July issue of the Journal of Nuclear Medicine.

July 12, 2017

Philips, Varian, IBA partner on Singapore cancer center

By AuntMinnie.com staff writers

Royal Philips plans to collaborate with Varian Medical Systems and Ion Beam Applications (IBA) Worldwide to build a new oncology research and training center in Biopolis, an international biomedical research hub in Singapore.

July 11, 2017

PET agent could advance blood clot imaging

By AuntMinnie.com staff writers

German researchers are developing an imaging method that uses a ligand labeled with F-18 to target glycoprotein IIb/IIIa receptors, potentially improving the visualization of blood clots in veins and arteries, according to a preclinical study published in the July issue of the Journal of Nuclear Medicine.

July 6, 2017

FDA responds to IsoRay's GammaTile 510(k)

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has issued a response to medical isotope developer IsoRay's pending 510(k) application for its GammaTile radiation therapy system.

July 5, 2017

MILabs completes UPenn installation

By AuntMinnie.com staff writers

Molecular imaging developer MILabs has installed a preclinical micro-CT scanner in the department of radiology at the University of Pennsylvania (UPenn).

July 5, 2017

PBS report targets price hike for V/Q radiotracers

By Wayne Forrest

Escalating costs for two radiopharmaceuticals used for ventilation/perfusion (V/Q) nuclear medicine scans in lung and kidney imaging are drawing the ire of pharmacies that prepare the materials for distribution to hospitals in the U.S., according to a June 30 report by PBS NewsHour.

June 29, 2017

FDG-PET links physical activity to healthy brains

By AuntMinnie.com staff writers

Researchers using FDG-PET have uncovered healthy patterns of glucose metabolism in the brains of people at risk for Alzheimer's disease who consistently partake in moderate-intensity physical activity, according to a study published online June 22 in the Journal of Alzheimer's Disease.

June 22, 2017

Navidea signs distributor for India

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals has inked an exclusive licensing and distribution agreement with Sayre Therapeutics of Bangalore, India.

June 19, 2017

CereScan shows updated CereMetrix at SNMMI 2017

By AuntMinnie.com staff writers

Neurodiagnostic firm CereScan showcased new features on its CereMetrix database at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.

June 18, 2017

Cerveau gets IND for tau imaging agent

By AuntMinnie.com staff writers

Radiopharmaceutical developer Cerveau Technologies said the U.S. Food and Drug Administration has given its MK-6240 tau imaging agent investigational new drug (IND) status.

June 18, 2017

Previous Page

Page 98 of 445

Next Page